Skip to main content

Table 4 Expression levels of mammalian proteins expressed with N-terminal H10-MBP fusions, with selected protein features

From: Production of soluble mammalian proteins in Escherichia coli: identification of protein features that correlate with successful expression

No.

Protein

Accession No.

PfamA Domaina

Construct

MW (kDa)

hp_aa

LC

Total Expression (mg / l)

Soluble Expression (mg / l)

31

TAL1

P17542

HLH

179–331/331

16.5

3.0

1.0

13.2

8.3

32

ELF1

P32519

Ets

2–619/619

67.4

6.0

5.0

0.0

0.0

33

ELF1

P32519

nab

2–167/619

18.0

4.0

2.0

14.6

14.6

34

ELF1

P32519

Ets

204–619/619

45.4

6.0

2.0

0.0

0.0

35

ELF1

P32519

na

316–619/619

32.2

3.0

1.0

0.0

0.0

36

ELF1

P32519

Ets

204–306/619

12.1

6.0

0.0

65.0

19.3

37

Elf1

Q60775

Ets

2–612/612

66.1

6.0

4.0

24.0

23.5

38

Elf1

Q60775

Ets

2–306/612

34.0

6.0

3.0

60.6

27.2

39

Elf1

Q60775

na

2–167/612

17.8

4.0

2.0

8.6

8.4

40

Elf1

Q60775

Ets

204–612/612

44.2

6.0

1.0

15.5

10.4

41

Elf1

Q60775

Ets

204–306/612

12.1

6.0

0.0

18.5

12.1

42

Elf1

Q60775

na

316–612/612

30.7

3.0

0.0

0.0

0.0

43

Gata1

P17679

GATA × 2

2–413/413

42.5

3.0

6.0

16.0

14.3

44

Gata1

P17679

GATA × 2

2–319/413

33.8

3.0

5.0

67.0

15.8

45

Gata1

P17679

na

2–182/413

18.6

3.0

3.0

9.7

7.2

46

Gata1

P17679

GATA × 2

191–413/413

23.1

3.0

5.0

19.7

9.6

47

Gata1

P17679

GATA × 2

191–319/413

14.3

3.0

0.0

0.0

0.0

48

Gata2

O09100

GATA × 2

2–480/480

50.3

5.0

5.0

0.0

0.0

49

Gata2

O09100

na

2–189/480

19.4

4.0

2.0

0.0

0.0

50

Gata2

O09100

GATA × 2

275–480/480

22.4

5.0

2.0

0.0

0.0

51

Gata2

O09100

GATA × 2

275–402/480

14.2

1.0

1.0

0.0

0.0

52

Fli1

P26323

SAM_PNT, Ets

2–452/452

50.9

3.0

1.0

0.0

0.0

53

Fli1

P26323

SAM_PNT, Ets

2–363/452

41.7

3.0

0.0

134.5

61.0

54

Fli1

P26323

SAM_PNT

2–198/452

22.2

3.0

0.0

121.2

86.8

55

Fli1

P26323

SAM_PNT, Ets

114–452/452

38.6

3.0

1.0

61.0

38.2

56

Fli1

P26323

SAM+ETS

114–363/452

29.4

3.0

0.0

96.5

73.1

57

Fli1

P26323

SAM_PNT

114–196/452

10.0

3.0

0.0

71.8

51.7

58

Fli1

P26323

Ets

280–452/452

20.1

3.0

1.0

28.6

16.3

59

Fli1

P26323

Ets

280–363/452

10.9

3.0

0.0

23.4

23.0

60

Lmo2

P25801

LIM × 2

2–158/158

18.2

3.0

0.0

106.7

23.8

61

Ldb1

P70662

LIM_bind

2–375/375

42.6

3.0

2.0

0.0

0.0

62

Ldb1

P70662

LIM_bind

2–273/375

31.9

3.0

0.0

133.8

62.0

63

Ldb1

P70662

LIM_bind

275–375/375

10.5

2.0

1.0

2.0

1.7

64

Lyl1

P27792

HLH

40–278/278

26.2

3.0

0.0

3.8

2.6

65

Lyl1

P27792

HLH

40–215/278

19.6

3.0

0.0

4.2

2.5

66

Lyl1

P27792

na

40–135/278

10.3

3.0

0.0

3.6

1.7

67

Lyl1

P27792

HLH

150–278/278

14.8

3.0

0.0

40.1

32.2

68

Lyl1

P27792

HLH

150–215/278

8.2

3.0

0.0

60.3

20.8

69

Ttr

P07309

transthyretin

20–147/147

13.6

5.0

0.0

59.2

49.7

70

Pin1

Q9QUR7

WW, Rotamase

2–163/163

18.2

2.0

0.0

36.9

19.4

71

Whsc1

Q7TSF5

PHD × 2, PWWP, SET

2–558/558

63.8

4.0

2.0

9.4

1.3

72

Whsc1

Q7TSF5

PHD, PWWP, SET

2–373/558

43.0

4.0

0.0

21.6

12.4

73

Whsc1

Q7TSF5

PHD, PWWP

2–149/558

17.2

4.0

0.0

0.0

0.0

74

Whsc1

Q7TSF5

PWWP, SET, PHD

70–558/558

56.1

4.0

2.0

5.1

2.1

75

Whsc1

Q7TSF5

PWWP, SET

70–373/558

35.3

4.0

0.0

18.2

17.9

76

Whsc1

Q7TSF5

PWWP

70–149/558

9.5

4.0

0.0

56.8

14.6

77

Whsc1

Q7TSF5

SET

249–373/558

14.3

4.0

0.0

34.7

22.6

78

Maat1

NM_024227

na

2–257/257

30.0

3.0

0.0

2.7

2.4

79

BC031407

NM_145596

na

2–630/630

67.3

6.0

6.0

0.0

0.0

80

BC031407

NM_145596

na

2–455/630

48.5

6.0

5.0

0.0

0.0

81

BC031407

NM_145596

na

2–179/630

19.4

4.0

1.0

9.6

8.7

82

BC031407

NM_145596

na

178–630/630

48.0

6.0

5.0

0.0

0.0

83

BC031407

NM_145596

na

178–455/630

29.1

6.0

4.0

0.0

0.0

84

BC031407

NM_145596

na

413–630/630

23.7

4.0

1.0

0.0

0.0

85

Bzrp2

P50637

TspO_MBR

2–169/169

18.7

4.0

0.0

0.0

0.0

86

MGC19339

NM_145954

Aldedh

40–486/803

47.0

5.0

2.0

37.2

18.7

87

Bsg

NM_009768

Ig × 2, V-set

28–323/389

32.4

4.0

0.0

61.2

36.6

88

Snx15

NM_026912

PX, MIT

2–337/337

37.6

4.0

1.0

32.4

32.0

89

Snx15

NM_026912

PX

2–226/337

25.6

4.0

1.0

20.0

18.8

90

Atp2b2

Q9R0K7

Cation_ATPase_N

2–94/1198

10.4

2.0

0.0

42.1

24.7

91

Atp2b2

Q9R0K7

Cation_ATPase_N

1039–1198/1198

17.9

2.0

3.0

6.1

5.0

92

cdh23

Q99PF4

Cadherin

33–132/3354

11.1

4.0

0.0

174.7

38.8

93

Myo15

Q9QZZ4

SH3_2

2847–2937/3511

9.8

4.0

0.0

8.6

0.0

94

Myo7a

P97479

SH3_1

1602–1672/2215

7.8

4.0

0.0

76.0

35.4

95

tmc1

Q8R4P5

na

2–193/757

22.9

3.0

3.0

0.0

0.0

96

Trvp4

NM_022017

na

500–718/871

24.6

9.0

0.0

0.0

0.0

97

Whrn

XM_196324

PDZ

811–908/908

11.0

3.0

0.0

34.1

31.1

98

Espn

NM_019585

WH2

2–253/253

28.0

3.0

2.0

5.5

3.8

99

Map2

P20357

Tubulin-binding

1657–1755/1828

10.6

2.0

0.0

47.1

46.8

100

Prom

O54990

Prominin

124–162/867

4.3

2.0

1.0

16.3

8.5

101

GluR1

P23818

ANF_receptor

19–538/907

59.0

4.0

0.0

0.0

0.0

102

GluR2

P23819

ANF_receptor

22–545/883

58.6

4.0

0.0

0.0

0.0

103

Grin1

P35438

na

834–938/938

12.0

5.0

0.0

13.8

13.8

104

Grin2a

P35436

na

23–555/1464

59.9

6.0

0.0

58.5

8.2

105

Grin2b

Q01097

Lig_chan

656–817/1482

18.1

4.0

0.0

0.0

0.0

106

Dlgh2

NM_011807

PDZ

419–530/852

11.7

4.0

0.0

13.8

13.7

107

Dlgh4

Q62108

PDZ

311–394/724

8.7

4.0

0.0

37.4

29.2

108

Dlgh3

P70175

PDZ

402–509/849

11.7

5.0

0.0

0.0

0.0

109

Dlgh1

U93309

PDZ

432–572/927

15.1

5.0

0.0

26.7

23.4

110

Syngap1

XM_139847

RasGAP

405–615/1318

23.9

3.0

0.0

0.0

0.0

111

Grip1

Q925T5

PDZ

1–112/1034

9.6

3.0

0.0

0.0

0.0

112

Homer1

Q9Z2Y3

WH1

2–107/354

12.1

3.0

0.0

17.9

17.6

113

Homer3

Q99JP6

WH1

2–110/356

39.3

4.0

0.0

0.0

0.0

114

TtyhI

Q9EQN7

na

263–450/450

20.6

5.0

0.0

35.6

28.3

115

1500001H12RIKEXT2

NM_021316

na

2–149/149

14.8

5.0

3.0

66.1

66.1

116

Ext2

NM_010163

na

99–392/718

33.0

4.0

0.0

18.5

3.5

117

KIAA1136

Q9ULT3

na

45–214/597

19.2

2.0

0.0

26.8

10.4

118

G2

Q12914

na

1046–1692/1692

71.3

5.0

3.0

0.0

0.0

119

KIAA1549

Q9HCM3

na

184–464/1865

29.5

5.0

4.0

3.5

0.0

120

Nfkb1

P25799

RHD

39–365/971

36.7

5.0

0.0

27.1

22.7

121

Nfkb1

P25799

RHD, TIG, Ank × 6, Death

2–971/971

105.5

7.0

3.0

0.0

0.0

122

RelA-p65

Q04207

RHD, TIG

18–306/549

32.9

4.0

0.0

24.1

18.2

123

RelA-p65

Q04207

RHD, TIG

2–549/549

60.0

5.0

2.0

0.0

0.0

124

RelB

Q04863

RHD, TIG

102–418/558

35.8

4.0

0.0

46.0

25.9

125

myog

P12979

HLH, Basic

2–224/224

25.1

3.0

1.0

25.8

12.4

  1. Features listed as Table 1 except: aPfamA domains contained within expressed protein and bna – no PfamA domains annotated.